According to Voyager Therapeutics 's latest financial reports the company's current EPS (TTM) is $2.39. In 2022 the company made an earnings per share (EPS) of -$1.21 an increase over its 2021 EPS that were of -$1.90.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.39 | -297.52% |
2022 | -$1.21 | -36.32% |
2021 | -$1.90 | -293.88% |
2020 | $0.98 | -177.78% |
2019 | -$1.26 | -54.35% |
2018 | -$2.76 | 3.37% |
2017 | -$2.67 | 68.99% |
2016 | -$1.58 | -26.71% |
2015 | -$2.16 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -191.21% | ๐บ๐ธ USA |